Guru Ownership Trend
Guru Analysis for PTC Therapeutics, Inc. (PTCT)
PTC Therapeutics, Inc. (PTCT), a key player in the Healthcare sector, continues to attract institutional attention.
As of Q2 2026, a total of 9 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $190.36 M.
Top institutional holders include Jefferies Group and Renaissance Technologies (RenTech).
Institutional sentiment is currently Bullish. This is evidenced by a $10.59 M net inflow during the quarter.
Recent activity highlights Manning & Napier Group who increased their stake by 121.4%. Conversely, Chuck Royce reduced exposure by 89.7%.
Key Holders
Top 5 by Value
Top 5 by Conviction
Recent Activity Breakdown (Q2 2026)
Guru Consensus (Q2 2026)
FAQs for PTC Therapeutics, Inc. (PTCT)
Major holders include Jefferies Group ($110.69 M), Renaissance Technologies (RenTech) ($59.02 M), Cliff Asness ($27.1 M). According to the latest reported data, 9 tracked investment managers collectively hold approximately 2.58 M shares.
According to the latest 13F reporting period, sentiment appears Bullish (Net Buying). There was a net inflow of $10.59 M, with 5 managers increasing positions and 4 managers reducing holdings.
During the most recent reporting period, 4 managers trimmed their positions, while 0 fully exited PTCT. The total reported sell value was $10.23 M.
Yes, 1 managers opened new positions in PTCT, and 4 increased their existing holdings. The total reported buy value was $20.82 M.
